Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer
Author:
Affiliation:
1. Department of Thoracic Surgery; Sun Yat-sen University Cancer Center; Guangzhou Guangdong Province China
2. State Key Laboratory of Oncology in South China; Guangzhou Guangdong Province China
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine,Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12058/fullpdf
Reference27 articles.
1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005
2. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N Engl J Med,2005
3. Prognosis of patients with resected non-small cell lung cancer: impact of clinical and pathologic variables;Ravdin;Lung Cancer,2006
4. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008
5. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial;Waller;Eur J Cardiothorac Surg,2004
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluating clinical and radiomic features for predicting lung cancer recurrence pre- and post-tumor resection;Medical Imaging 2024: Image Processing;2024-04-02
2. Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells;Diagnostics;2023-12-07
3. Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study;Clinical Cancer Research;2023-05-26
4. Early-Stage Lung Cancer in the Era of Precision Oncology: From Immunotherapy to Targeted Therapy;Interventional Oncology;2023
5. Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial;Translational Lung Cancer Research;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3